{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:15:45Z","timestamp":1767824145830,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00467-005-2032-4","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T07:54:32Z","timestamp":1124783672000},"page":"1750-1755","source":"Crossref","is-referenced-by-count":21,"title":["Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy"],"prefix":"10.1007","volume":"20","author":[{"given":"Sauwalak","family":"Opastirakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wattana","family":"Chartapisak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"2032_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/pmj.78.924.599","volume":"78","author":"Loannou","year":"2002","unstructured":"Loannou Y, Isenberg DA (2002) Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J 78:599\u2013606","journal-title":"Postgrad Med J"},{"key":"2032_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-857X(05)70143-5","volume":"26","author":"Ortmann","year":"2000","unstructured":"Ortmann RA, Klippel JH (2000) Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am 26:363\u2013375","journal-title":"Rheum Dis Clin North Am"},{"key":"2032_CR3","first-page":"2","volume":"19","author":"Austin","year":"1999","unstructured":"Austin HA, Balow JE (1999) Natural history and treatment of lupus nephritis. Semin Nephrol 19:2\u201311","journal-title":"Semin Nephrol"},{"key":"2032_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","volume":"6","author":"Martin","year":"1997","unstructured":"Martin F, Lauwerys B, Lefe\u2019bvre C, Devogelaer J-P, Houssiau FA (1997) Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 6:254\u2013257","journal-title":"Lupus"},{"key":"2032_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-857X(05)70327-6","volume":"23","author":"Segal","year":"1997","unstructured":"Segal BH, Sneller MC (1997) Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 23:219\u2013237","journal-title":"Rheum Dis Clin North Am"},{"key":"2032_CR6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"Austin","year":"1986","unstructured":"Austin HA 3rd, Klippel JH, Balow JE, Le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis: controlled trial of prednisolone and cytotoxic drugs. N Engl J Med 314:614\u2013619","journal-title":"N Engl J Med"},{"key":"2032_CR7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780390906","volume":"39","author":"Pryor","year":"1996","unstructured":"Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475\u20131482","journal-title":"Arthritis Rheum"},{"key":"2032_CR8","first-page":"271","volume":"55","author":"Nived","year":"1985","unstructured":"Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. QJM 55:271\u2013287","journal-title":"QJM"},{"key":"2032_CR9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"2032_CR10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0049-0172(96)80018-7","volume":"25","author":"Illiopoulos","year":"1996","unstructured":"Illiopoulos AG, Tsokos QC (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 25:318\u2013336","journal-title":"Semin Arthritis Rheum"},{"key":"2032_CR11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/ard.60.12.1141","volume":"60","author":"No","year":"2001","unstructured":"No\u00ebl V, Lortholary O, Casassus P, Cohen P, G\u00e9n\u00e9reau T, Adre M-H, Mouthon L, Guillevin L (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60:1141\u20131144","journal-title":"Ann Rheum Dis"},{"key":"2032_CR12","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.128.6.2453","volume":"128","author":"Cupps","year":"1982","unstructured":"Cupps TR, Edgar LC, Fauci AS (1982) Suppression of human B-lymphocyte function by cyclophosphamide. J Immunol 128:2453\u20132457","journal-title":"J Immunol"},{"key":"2032_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/art.1780210107","volume":"21","author":"Ginzler","year":"1978","unstructured":"Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21:37\u201344","journal-title":"Arthritis Rheum"},{"key":"2032_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00005792-198709000-00002","volume":"66","author":"Hellmann","year":"1987","unstructured":"Hellmann DB, Petri M, Whiting-O\u2019Keefe Q (1987) Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine 66:341\u2013348","journal-title":"Medicine"},{"key":"2032_CR15","unstructured":"Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M (1993) Infection in systemic lupus erythematosus. J Med Assoc Thai 542\u2013548"},{"key":"2032_CR16","first-page":"the","volume":"erythematosus","author":"Rubin","year":"1985","unstructured":"Rubin LA, Urowitz MD, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. QJM 87\u201398","journal-title":"Mortality in systemic lupus"},{"key":"2032_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780170102","volume":"17","author":"Staple","year":"1974","unstructured":"Staple PJ, Gerding DN, Decker JL, Gordon RS Jr (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1\u201310","journal-title":"Arthritis Rheum"},{"key":"2032_CR18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","volume":"119","author":"Boumpas","year":"1993","unstructured":"Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993) Glucocorticoid therapy for immune-mediated diseases. Basic and clinical correlates. Ann Intern Med 119:1198\u20131208","journal-title":"Ann Intern Med"},{"key":"2032_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(05)70016-8","volume":"24","author":"Petri","year":"1998","unstructured":"Petri M (1998) Infection in systemic lupus erythematosus. Rheum Clin North Am 24:423\u2013456","journal-title":"Rheum Clin North Am"},{"key":"2032_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/qjmed\/89.7.531","volume":"89","author":"Paton","year":"1996","unstructured":"Paton NIJ, Cheong IKS, Kong NCT, Segasothy M (1996) Risks factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89:531\u2013538","journal-title":"QJM"},{"key":"2032_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0049-0172(90)90059-O","volume":"20","author":"Piliero","year":"1990","unstructured":"Piliero P, Furie F (1990) Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 20:185\u2013189","journal-title":"Semin Arthritis Rheum"},{"key":"2032_CR22","first-page":"1559","volume":"19","author":"Petri","year":"1992","unstructured":"Petri MP, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 19:1559\u20131565","journal-title":"J Rheumatol"},{"key":"2032_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0090-1229(92)90085-3","volume":"63","author":"Winfield","year":"1992","unstructured":"Winfield JB, Mimura T (1992) Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 63:13\u201316","journal-title":"Clin Immunol Immunopathol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-2032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-005-2032-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-2032-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:57:02Z","timestamp":1683187022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-005-2032-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,24]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s00467-005-2032-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,24]]}}}